MAP2K2 and acute respiratory distress syndrome: MAP2K1 and MAP2K2, integral to the MAPK/ERK signaling pathway, have been shown to regulate inflammation and interferon responses, with MAP2K2 deactivation promoting the resolution of acute lung injury (ALI) (Sarkar et al., 2022).